ALL vs TERN · P/E 4.9, $56.89B cap vs $6.12B cap
The Allstate Corporation (ALL) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
ALL does not have a complete income-statement cache yet.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the ALL and TERN stock pages for the full models.
Not investment advice.